{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:01:06Z","timestamp":1794376866286,"version":"4.9.0"},"reference-count":154,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,2,14]],"date-time":"2008-02-14T00:00:00Z","timestamp":1202947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Comparative Oncology"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cisplatin is a platinum chemotherapeutic used in a variety of malignancies. The antineoplastic activity occurs from DNA cross\u2010links and adducts, in addition to the generation of superoxide radicals. Nephrotoxicity is the most well\u2010known and potentially most clinically significant toxicity. Unfortunately, the mechanism for cisplatin nephrotoxicity has not been completely elucidated; however, many theories have been developed. Other toxicities include gastrointestinal, myelosuppression, ototoxicity and neurotoxicity. Saline diuresis is currently the most accepted way to prevent cisplatin nephrotoxicity. Research has focused on pharmaceuticals and enzyme\/molecular alterations as alternatives to long\u2010term diuresis. No agents have currently been identified that can protect from all toxicities. Cisplatin has shown activity against osteosarcoma, transitional cell carcinoma, squamous cell carcinoma (SCC), melanoma, mesothelioma, carcinomatosis and germinal cell tumours in the dog. In the cat, cisplatin cannot be utilized because of fulminant pulmonary oedema that occurs at standard doses. Intralesional cisplatin has been utilized in horses for the treatment of SCC and sarcoids.<\/jats:p>","DOI":"10.1111\/j.1476-5829.2007.00142.x","type":"journal-article","created":{"date-parts":[[2008,2,15]],"date-time":"2008-02-15T03:42:14Z","timestamp":1203046934000},"page":"1-18","source":"Crossref","is-referenced-by-count":396,"title":["Cisplatin: a review of toxicities and therapeutic applications"],"prefix":"10.1111","volume":"6","author":[{"given":"K.","family":"Barabas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Milner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Adin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,2,14]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/205698a0"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/222385a0"},{"key":"e_1_2_10_4_2","first-page":"288","article-title":"Cisplatin, a new antineoplastic drug in veterinary medicine","volume":"186","author":"Page R","year":"1985","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_10_5_2","first-page":"332","volume-title":"Cancer Chemotherapy and Biotherapy Principles and Practice","author":"Reed E","year":"2006"},{"key":"e_1_2_10_6_2","first-page":"1223","article-title":"Renal handling of cis\u2010diamminedichloroplatinum(II)","volume":"64","author":"Jacobs C","year":"1980","journal-title":"Cancer Treatment Reports"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(80)90086-1"},{"key":"e_1_2_10_8_2","first-page":"2340","article-title":"Distribution and disposition of platinum following intravenous administration of cis\u2010diamminedichloroplatinum(II) (NSC 119875) to dogs","volume":"36","author":"Litterst CL","year":"1976","journal-title":"Cancer Research"},{"key":"e_1_2_10_9_2","first-page":"169","article-title":"Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity","volume":"67","author":"Campbell AB","year":"1983","journal-title":"Cancer Treatment Reports"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197704)39:4<1357::AID-CNCR2820390402>3.0.CO;2-C"},{"key":"e_1_2_10_11_2","first-page":"521","volume-title":"Handbook of Physiology. Renal Physiology","author":"Weiner IM","year":"1973"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1984.86"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00254171"},{"key":"e_1_2_10_14_2","first-page":"1433","article-title":"Anticancer activity of cis\u2010dichlorodiammineplatinum(II) and some relevant chemistry","volume":"63","author":"Rosenberg B","year":"1979","journal-title":"Cancer Treatment Reports"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01966766"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910060207"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(70)90102-4"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(82)80004-2"},{"key":"e_1_2_10_19_2","first-page":"643","article-title":"Biologic and chemical effects of cis\u2010dichlorodiammineplatinum (II) (NSC\u2010119875) on DNA","volume":"59","author":"Munchausen LL","year":"1975","journal-title":"Cancer Chemotherapy Reports"},{"key":"e_1_2_10_20_2","first-page":"3821","article-title":"Template primer inactivation by cis\u2010 and trans\u2010dichlorodiammine platinum for human DNA polymerase alpha, beta, and Rauscher murine leukemia virus reverse transcriptase, as a mechanism of cytotoxicity","volume":"36","author":"Harder HC","year":"1976","journal-title":"Cancer Research"},{"key":"e_1_2_10_21_2","first-page":"2043","article-title":"Induction and repair of DNA cross\u2010links in Chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity","volume":"44","author":"Plooy AC","year":"1984","journal-title":"Cancer Research"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.2306"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(98)00328-1"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.7.3070"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(90)90364-Q"},{"key":"e_1_2_10_26_2","doi-asserted-by":"crossref","first-page":"16121","DOI":"10.1016\/S0021-9258(18)41975-8","article-title":"Properties of the reaction of cis\u2010dichlorodiammineplatinum(II) with metallothionein","volume":"267","author":"Pattanaik A","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3175622"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.16.1295"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(98)90056-1"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.07.056"},{"key":"e_1_2_10_31_2","first-page":"1763","article-title":"Resistance to cytotoxic drugs in DNA mismatch repair\u2010deficient cells","volume":"3","author":"Aebi S","year":"1997","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.33.19645"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690176"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(98)00224-X"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(86)80112-3"},{"key":"e_1_2_10_36_2","doi-asserted-by":"crossref","unstructured":"BlachleyJDandHillJB.Renal and electrolyte disturbances associated with cisplatin.Annals of Internal Medicine1981;95:628\u2013632.","DOI":"10.7326\/0003-4819-95-5-628"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(78)90825-2"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197804)41:4<1274::AID-CNCR2820410410>3.0.CO;2-F"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1159\/000168693"},{"key":"e_1_2_10_40_2","first-page":"551","article-title":"Mechanism of cis\u2010platinum nephrotoxicity: II. Morphologic observations","volume":"213","author":"Dobyan DC","year":"1980","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_10_41_2","first-page":"831","article-title":"Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia","volume":"140","author":"Schumer M","year":"1992","journal-title":"American Journal of Pathology"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000042803.28024.92"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.1987.tb00200.x"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(78)90014-3"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00078.2002"},{"key":"e_1_2_10_46_2","first-page":"F1211","article-title":"The p53\u2010independent activation of transcription of p21 WAF1\/CIP1\/SDI1 after acute renal failure","volume":"271","author":"Megyesi J","year":"1996","journal-title":"American Journal of Physiology"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1497"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00192.2003"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.12.040172.002111"},{"key":"e_1_2_10_50_2","first-page":"545","article-title":"Mechanism of cis\u2010platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys","volume":"213","author":"Levi J","year":"1980","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_10_51_2","first-page":"F700","article-title":"Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis","volume":"270","author":"Lieberthal W","year":"1996","journal-title":"American Journal of Physiology"},{"key":"e_1_2_10_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/74994"},{"key":"e_1_2_10_53_2","first-page":"F1181","article-title":"Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules","volume":"258","author":"Brady HR","year":"1990","journal-title":"American Journal of Physiology"},{"key":"e_1_2_10_54_2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-3565(24)36493-6","article-title":"Cisplatin\u2010induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain","volume":"280","author":"Kruidering M","year":"1997","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_10_55_2","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.V12122683","article-title":"Manganese superoxide dismutase attenuates cisplatin\u2010induced renal injury: importance of superoxide","volume":"12","author":"Davis CA","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"e_1_2_10_56_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00687.x"},{"key":"e_1_2_10_57_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.49.34974"},{"key":"e_1_2_10_58_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.302.1.8"},{"key":"e_1_2_10_59_2","doi-asserted-by":"publisher","DOI":"10.1080\/15287390306449"},{"key":"e_1_2_10_60_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.300.1.142"},{"key":"e_1_2_10_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63035-0"},{"key":"e_1_2_10_62_2","first-page":"5925","article-title":"Inhibition of gamma\u2010glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin\u2010induced toxicity","volume":"54","author":"Hanigan MH","year":"1994","journal-title":"Cancer Research"},{"key":"e_1_2_10_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(95)00098-4"},{"key":"e_1_2_10_64_2","doi-asserted-by":"crossref","first-page":"20116","DOI":"10.1016\/S0021-9258(20)80702-9","article-title":"Glutathione\u2010associated cis\u2010diamminedichloroplatinum(II) metabolism and ATP\u2010dependent efflux from leukemia cells. Molecular characterization of glutathione\u2010platinum complex and its biological significance","volume":"268","author":"Ishikawa T","year":"1993","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_10_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1996.tb02913.x"},{"key":"e_1_2_10_66_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/20.4.553"},{"key":"e_1_2_10_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0270-9295(03)00089-5"},{"key":"e_1_2_10_68_2","first-page":"F175","article-title":"Cisplatin nephrotoxicity in rats: defect in papillary hypertonicity","volume":"241","author":"Safirstein R","year":"1981","journal-title":"American Journal of Physiology"},{"key":"e_1_2_10_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1982.8"},{"key":"e_1_2_10_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1981.19"},{"key":"e_1_2_10_71_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00694330"},{"key":"e_1_2_10_72_2","first-page":"1076","article-title":"Evaluation of a short\u2010term saline diuresis protocol for the administration of cisplatin","volume":"49","author":"Ogilvie GK","year":"1988","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_10_73_2","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2460\/javma.1993.202.11.1845","article-title":"Prevalence of nephrotoxicosis associated with a four\u2010hour saline solution diuresis protocol for the administration of cisplatin to dogs with naturally developing neoplasms","volume":"202","author":"Ogilvie GK","year":"1993","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_10_74_2","first-page":"73","article-title":"High\u2010dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity","volume":"65","author":"Ostrow S","year":"1981","journal-title":"Cancer Treatment Reports"},{"key":"e_1_2_10_75_2","first-page":"1269","article-title":"Effects of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis\u2010dichlorodiammineplatinum\u2010(II) in rats","volume":"39","author":"Pera MF","year":"1979","journal-title":"Cancer Research"},{"key":"e_1_2_10_76_2","unstructured":"Al\u2010SarrafM.Clinical trial of cis\u2010platinum (NSC\u2010119875): hydration with and without mannitol in patients with previously treated advanced malignant melanoma. Proc Am Assoc Cancer Res and ASCO1979;20:185."},{"key":"e_1_2_10_77_2","unstructured":"BeltRJandTaylorS.Randomized trial of hydration and mannitol in preventingcis\u2010platinum induced nephrotoxicity.Proceedings of the American Association for Cancer Research and the American Society of Clinical Oncology1979;20:388."},{"key":"e_1_2_10_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(81)90011-9"},{"key":"e_1_2_10_79_2","first-page":"57","article-title":"Selective inhibition of the nephrotoxicity of cis\u2010dichlorodiammineplatinum(II) by WR\u20102721 without altering its antitumor properties","volume":"64","author":"Yuhas JM","year":"1980","journal-title":"Cancer Treatment Reports"},{"key":"e_1_2_10_80_2","first-page":"2974","article-title":"Mechanism of cisplatin nephrotoxicity","volume":"42","author":"Weiner MW","year":"1983","journal-title":"Federation Proceedings"},{"key":"e_1_2_10_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-0590(92)90044-I"},{"key":"e_1_2_10_82_2","first-page":"2745","article-title":"Effect of diethyldithiocarbamate on cis\u2010diamminedichloro\u2010platinum(II)\u2010induced cytotoxicity, DNA cross\u2010linking, and gamma\u2010glutamyl transpeptidase inhibition","volume":"46","author":"Bodenner DL","year":"1986","journal-title":"Cancer Research"},{"key":"e_1_2_10_83_2","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1200\/JCO.1990.8.9.1585","article-title":"Modification of cisplatin toxicity with diethyldithiocarbamate","volume":"8","author":"Beny JM","year":"1990","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_10_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910315)67:6<1518::AID-CNCR2820670610>3.0.CO;2-3"},{"key":"e_1_2_10_85_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.075119"},{"key":"e_1_2_10_86_2","first-page":"1426","article-title":"Intraperitoneal cis\u2010diamminedichloroplatinum with systemic thiosulfate protection","volume":"43","author":"Howell SB","year":"1983","journal-title":"Cancer Research"},{"key":"e_1_2_10_87_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.087601"},{"key":"e_1_2_10_88_2","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1996.0233"},{"key":"e_1_2_10_89_2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-3565(24)39304-8","article-title":"Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin\u2010procainamide complex play a role?","volume":"293","author":"Viale M","year":"2000","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_10_90_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00686018"},{"key":"e_1_2_10_91_2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2460\/ajvr.1998.59.03.286","article-title":"Preclinical evaluation of a sterically stabilized liposome\u2010encapsulated cisplatin in clinically normal cats","volume":"59","author":"Thamm DH","year":"1998","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_10_92_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2460\/ajvr.1999.60.02.257","article-title":"Evaluation of toxicosis of liposome\u2010encapsulated cis\u2010bis\u2010neodecanoato\u2010trans\u2010R,R\u20101,2\u2010diaminocyclohexane platinum (II) in clinically normal cats","volume":"60","author":"Fox LE","year":"1999","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_10_93_2","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2004.65.1474"},{"key":"e_1_2_10_94_2","first-page":"267","article-title":"Amelioration of cis\u2010platinum nephrotoxicity by orgotein (superoxide dismutase)","volume":"10","author":"McGinness JE","year":"1978","journal-title":"Physiological Chemistry and Physics"},{"key":"e_1_2_10_95_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2000.278.2.H643"},{"key":"e_1_2_10_96_2","first-page":"71: 177","article-title":"Generation of bile pigments by haem oxygenase: a refined cellular strategy in response to stressful insults","author":"Foresti R","year":"2004","journal-title":"Biochemical Society Symposium"},{"key":"e_1_2_10_97_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.83.5.568"},{"key":"e_1_2_10_98_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702212"},{"key":"e_1_2_10_99_2","doi-asserted-by":"publisher","DOI":"10.1038\/74680"},{"key":"e_1_2_10_100_2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1096\/fj.03-0996fje","article-title":"Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs","volume":"18","author":"Lavitrano M","year":"2004","journal-title":"Federation of American Societies for Experimental Biology Journal"},{"key":"e_1_2_10_101_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2000.278.5.F726"},{"key":"e_1_2_10_102_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00363.2005"},{"key":"e_1_2_10_103_2","first-page":"36","article-title":"Hyperbilirubinemia protects against cisplatin nephrotoxicity","author":"Barabas K","year":"2006","journal-title":"Proceeding of the Veterinary Cancer Society"},{"key":"e_1_2_10_104_2","doi-asserted-by":"crossref","unstructured":"SchilskyRLandAndersonT.Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin.Annals of Internal Medicine1979;90:929\u2013931.","DOI":"10.7326\/0003-4819-90-6-929"},{"key":"e_1_2_10_105_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1985.217"},{"key":"e_1_2_10_106_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107159"},{"key":"e_1_2_10_107_2","first-page":"100","article-title":"Parathyroid function during chronic magnesium deficiency","volume":"131","author":"Connor TB","year":"1972","journal-title":"The Johns Hopkins Medical Journal"},{"key":"e_1_2_10_108_2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2460\/javma.1994.205.03.441","article-title":"Evaluation of butorphanol and cyproheptadine for prevention of cisplatin\u2010induced vomiting in dogs","volume":"205","author":"Moore AS","year":"1994","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_10_109_2","volume-title":"Veterinary Drug Handbook","author":"Plumb D","year":"2005"},{"key":"e_1_2_10_110_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5829.2006.00123.x"},{"key":"e_1_2_10_111_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197410)34:4<1005::AID-CNCR2820340407>3.0.CO;2-K"},{"key":"e_1_2_10_112_2","first-page":"6","volume-title":"Handbook of Clinical Audiology","author":"Green D","year":"1972"},{"key":"e_1_2_10_113_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563657808988252"},{"key":"e_1_2_10_114_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.6.754"},{"key":"e_1_2_10_115_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00262741"},{"key":"e_1_2_10_116_2","first-page":"42","article-title":"Ototoxicity in dogs and cats","volume":"8","author":"Pickrell JA","year":"1993","journal-title":"Seminars in Veterinary Medicine and Surgery (Small Animal)"},{"issue":"6","key":"e_1_2_10_117_2","first-page":"21","article-title":"High\u2010dose cisplatin therapy in ovarian cancer","volume":"12","author":"Ozols RF","year":"1985","journal-title":"Seminars in Oncology"},{"key":"e_1_2_10_118_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1995.tb00907.x"},{"key":"e_1_2_10_119_2","first-page":"507","article-title":"Use of cisplatin for treatment of appendicular osteosarcoma in dogs","volume":"192","author":"Shapiro W","year":"1988","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_10_120_2","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2460\/javma.1991.199.08.1057","article-title":"Osteogenic sarcoma and cisplatin chemotherapy in dogs: 16 cases (1986\u20131989)","volume":"199","author":"Rraegel SA","year":"1991","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_10_121_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1991.tb00950.x"},{"key":"e_1_2_10_122_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2460\/javma.1992.200.04.531","article-title":"Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979\u20131990)","volume":"200","author":"Thompson JP","year":"1992","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_10_123_2","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2460\/javma.1992.200.12.2005","article-title":"Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb\u2010sparing surgery: 22 cases (1987\u20131990)","volume":"200","author":"Berg J","year":"1992","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_10_124_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1988.tb00313.x"},{"key":"e_1_2_10_125_2","doi-asserted-by":"publisher","DOI":"10.5326\/0410382"},{"key":"e_1_2_10_126_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1343::AID-CNCR11>3.0.CO;2-#"},{"key":"e_1_2_10_127_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1988.tb01976.x"},{"key":"e_1_2_10_128_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-002-0469-8"},{"key":"e_1_2_10_129_2","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2004.10.008"},{"key":"e_1_2_10_130_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.1996.tb01961.x"},{"key":"e_1_2_10_131_2","first-page":"1530","article-title":"Cisplatin for treatment of transitional cell and squamous cell carcinomas in dogs","volume":"193","author":"Shapiro W","year":"1988","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_10_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(87)90015-0"},{"key":"e_1_2_10_133_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(90)90226-A"},{"issue":"6","key":"e_1_2_10_134_2","first-page":"31","article-title":"Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin","volume":"16","author":"Coughlin CT","year":"1989","journal-title":"Seminars in Oncology"},{"key":"e_1_2_10_135_2","first-page":"315","article-title":"Platinum\u2010radiation interactions","volume":"6","author":"Douple EB","year":"1988","journal-title":"National Cancer Institute Monographs"},{"key":"e_1_2_10_136_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.201.3.8939214"},{"key":"e_1_2_10_137_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1740-8261.2004.04068.x"},{"key":"e_1_2_10_138_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1740-8261.2004.04100.x"},{"key":"e_1_2_10_139_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2003.tb01329.x"},{"key":"e_1_2_10_140_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2460\/javma.1994.204.02.229","article-title":"Intralesional implant for treatment of primary oral malignant melanoma in dogs","volume":"204","author":"Kitchell BE","year":"1994","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_10_141_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1991.tb00953.x"},{"key":"e_1_2_10_142_2","doi-asserted-by":"publisher","DOI":"10.3109\/07357908309048508"},{"key":"e_1_2_10_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/0305-7372(86)90007-1"},{"key":"e_1_2_10_144_2","doi-asserted-by":"crossref","unstructured":"CharneySC BergmanPJ McKnightJA Farrelly J Novosad CA Leibman NF and Camps\u2010palau MA.Evaluation of intracavitary mitoxantrone and carboplatin for treatment of carcinomatosis sarcomatosis and mesothelioma with or without malignant effusions: a retrospective analysis of 12 cases (1997\u20132002). Veterinary and Comparative Oncology2005;3:171\u2013181.","DOI":"10.1111\/j.1476-5810.2005.00075.x"},{"key":"e_1_2_10_145_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1987.tb01983.x"},{"key":"e_1_2_10_146_2","first-page":"497","volume-title":"Current Veterinary Therapy X","author":"Shapiro W","year":"1989"},{"key":"e_1_2_10_147_2","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2000.61.791"},{"key":"e_1_2_10_148_2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2460\/javma.1993.202.02.261","article-title":"Intratumoral chemotherapy with cisplatin in oily emulsion in horses","volume":"202","author":"Theon AP","year":"1993","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_10_149_2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2460\/ajvr.1997.58.04.431","article-title":"Comparison of intratumoral administration of cisplatin versus bleomycin for treatment of periocular squamous cell carcinomas in horses","volume":"58","author":"Theon AP","year":"1997","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_10_150_2","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2460\/javma.1994.205.08.1170","article-title":"Perioperative intratumoral administration of cisplatin for treatment of cutaneous tumors in equidae","volume":"205","author":"Theon AP","year":"1994","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_10_151_2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2460\/javma.1999.215.11.1655","article-title":"Comparison of perioperative versus postoperative intratumoral administration of cisplatin for treatment of cutaneous sarcoids and squamous cell carcinomas in horses","volume":"215","author":"Theon AP","year":"1999","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_10_152_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1996.tb02031.x"},{"key":"e_1_2_10_153_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2004.tb02582.x"},{"key":"e_1_2_10_154_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1997.tb00465.x"},{"key":"e_1_2_10_155_2","first-page":"2765","article-title":"Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase II evaluation","volume":"22","author":"Kirpensteijn J","year":"2002","journal-title":"Anticancer Research"}],"container-title":["Veterinary and Comparative Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5829.2007.00142.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5829.2007.00142.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T15:55:38Z","timestamp":1738079738000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5829.2007.00142.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,14]]},"references-count":154,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1111\/j.1476-5829.2007.00142.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5829.2007.00142.x","archive":["Portico"],"relation":{},"ISSN":["1476-5810","1476-5829"],"issn-type":[{"value":"1476-5810","type":"print"},{"value":"1476-5829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,14]]}}}